TERN insider plans sale of 97,915 shares

TERN (Form 144) discloses a planned insider stock sale by Amy Burroughs.

Rhea-AI Filing Summary

TERN (Form 144) discloses a planned insider stock sale by Amy Burroughs. The notice covers an intended sale of 97,915 shares of common stock through Morgan Stanley Smith Barney LLC on or about 01/15/2026, with an indicated aggregate market value of $3,640,479.70. The filing notes that 90,079,781 shares of common stock were outstanding and identifies NASDAQ as the trading market.

The 97,915 shares were acquired on 01/15/2026 via a cash exercise of stock options granted by the issuer. The filing also reports that Amy Burroughs sold 71,339 common shares on 01/05/2026 for gross proceeds of $2,718,229.92 during the prior three months. By signing, the seller represents that she is not aware of undisclosed material adverse information about the company.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TERN shares does Amy Burroughs plan to sell under this Form 144?

The Form 144 reports an intended sale of 97,915 shares of TERN common stock.

What is the reported market value of the TERN shares to be sold?

The 97,915 TERN common shares to be sold have a reported aggregate market value of $3,640,479.70.

How and when did Amy Burroughs acquire the TERN shares being sold?

The shares were acquired on 01/15/2026 through a cash exercise of stock options granted by the issuer.

Has Amy Burroughs sold other TERN shares recently?

Yes. The filing states that on 01/05/2026 she sold 71,339 TERN common shares for gross proceeds of $2,718,229.92 during the past three months.

Which broker is handling the planned TERN share sale and on what exchange?

The planned sale is through Morgan Stanley Smith Barney LLC, and the shares are listed for trading on NASDAQ.

How many TERN common shares were outstanding according to this Form 144?

The notice states that 90,079,781 common shares of TERN were outstanding.

What representation does the seller make about inside information in this TERN Form 144?

By signing, the seller represents that she does not know any material adverse information about TERN’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/15/2026 - 04:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001872564
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TERNS PHARMACEUTICALS INC
SEC File Number	001-39926
Address of Issuer	1065 East Hillsdale Blvd., Suite 100 Foster City CALIFORNIA 94404
Phone	6505255535
Name of Person for Whose Account the Securities are To Be Sold	AMY BURROUGHS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	97915	3640479.70	90079781	01/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/15/2026	Exercise of Stock Options	Issuer			97915	01/15/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
AMY BURROUGHS 1065 East Hillsdale Blvd., Suite 100 Foster City CA 94404	Common	01/05/2026	71339	2718229.92

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	01/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/30/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Amy Burroughs
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)